article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Clinical trial monitoring Completing clinical studies more quickly can mean critical medicines and treatments reach patients faster. Companies that combine rapid innovation with speedy but safe trials can gain a multifaceted competitive advantage.

article thumbnail

Why VCs fell in love with pharma R&D in 2021

pharmaphorum

And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might. The risk equation changed for things like decentralised clinical trials, with companies that lacked the capacity for these trials falling behind.